Overview
Dysplastic gangliocytoma of the cerebellum, also known as Lhermitte-Duclos disease (LDD), is a rare, benign brain tumor characterized by cerebellar dysplastic changes. Approximately 200 cases have been reported in the literature 1.Diagnosis
Imaging: Magnetic resonance imaging (MRI) is crucial; diagnostic features include characteristic "tiger stripes" in adults, though less consistently seen in pediatric cases 1.
Prevalence: Preoperative diagnosis accuracy is 50% in adults and 16.7% in pediatric patients based on MRI findings 1.
Genetic Testing: Consider PTEN mutation testing and evaluation for comorbidities 1.Management
Surgical Resection: Total resection is recommended for optimal prognosis 1.
Hemorrhage Management: Address intratumoral hemorrhage surgically if encountered 1.Special Populations
Pediatrics: Diagnostic accuracy via MRI is lower compared to adults, with tiger stripe patterns less reliably observed 1.
Comorbidities: Evaluation for PTEN mutations and other comorbidities is advised 1.Key Recommendations
Utilize MRI for preoperative diagnosis, recognizing variability in diagnostic accuracy between adults and children 1. (Evidence: Moderate)
Aim for total surgical resection to achieve the best prognosis 1. (Evidence: Expert opinion)
Consider genetic testing for PTEN mutations and assess for associated comorbidities in patients diagnosed with LDD 1. (Evidence: Expert opinion)References
1 Ma J, Jia G, Chen S, Jia W. Clinical Perspective on Dysplastic Gangliocytoma of the Cerebellum (Lhermitte-Duclos Disease). World neurosurgery 2019. link